Cross Country Healthcare, Inc.
CCRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,344 | $2,020 | $2,803 | $1,677 |
| % Growth | -33.5% | -28% | 67.2% | – |
| Cost of Goods Sold | $1,070 | $1,569 | $2,179 | $1,302 |
| Gross Profit | $274 | $450 | $624 | $375 |
| % Margin | 20.4% | 22.3% | 22.3% | 22.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $246 | $303 | $0 | $211 |
| SG&A Expenses | $255 | $315 | $324 | $220 |
| Sales & Mktg Exp. | $9 | $12 | $0 | $10 |
| Other Operating Expenses | $36 | $23 | $30 | $16 |
| Operating Expenses | $291 | $338 | $355 | $236 |
| Operating Income | -$17 | $113 | $270 | $139 |
| % Margin | -1.3% | 5.6% | 9.6% | 8.3% |
| Other Income/Exp. Net | $0 | -$10 | -$17 | -$6 |
| Pre-Tax Income | -$16 | $103 | $253 | $133 |
| Tax Expense | -$2 | $30 | $67 | $1 |
| Net Income | -$15 | $73 | $186 | $132 |
| % Margin | -1.1% | 3.6% | 6.6% | 7.9% |
| EPS | -0.44 | 2.07 | 5.09 | 3.6 |
| % Growth | -121.3% | -59.3% | 41.4% | – |
| EPS Diluted | -0.44 | 2.05 | 5.02 | 3.53 |
| Weighted Avg Shares Out | 33 | 35 | 37 | 37 |
| Weighted Avg Shares Out Dil | 33 | 35 | 38 | 37 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $0 | $0 | $0 |
| Interest Expense | $2 | $8 | $14 | $7 |
| Depreciation & Amortization | $17 | $18 | $13 | $9 |
| EBITDA | $17 | $129 | $280 | $155 |
| % Margin | 1.2% | 6.4% | 10% | 9.2% |